Lv4
750 积分 2022-12-08 加入
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China
1天前
待确认
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
1天前
待确认
The Antiplatelet Effect of Six Non-Steroidal Anti-Inflammatory Drugs and Their Pharmacodynamic Interaction With Aspirin in Healthy Volunteers
1天前
待确认
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
1天前
待确认
Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the A merican Migraine Prevalence and Prevention ( AMPP ) Study
2天前
已完结
Evidence-based symptomatic treatment of migraine
2天前
已完结
Atrial fibrillation and migraine with aura in young adults with ischemic stroke
2天前
已完结
Real‐World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2‐Year Portuguese Multicenter Retrospective Cohort Study
2天前
待确认
Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)
3天前
已完结
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial
3天前
已完结
皖公网安备34019202002308
